PubRank

Jian-Hua Mao

Author PubWeight™ 80.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 2008 3.71
2 Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 2003 3.70
3 Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 2007 2.94
4 Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat Genet 2005 2.51
5 RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 2012 2.41
6 Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol 2007 2.23
7 Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 2002 2.04
8 Genomic segmental polymorphisms in inbred mouse strains. Nat Genet 2004 1.93
9 Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 2009 1.89
10 A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat Genet 2006 1.79
11 Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res 2005 1.71
12 HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci U S A 2007 1.58
13 Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 2007 1.54
14 Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling. Dev Cell 2011 1.50
15 CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res 2013 1.48
16 A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 2004 1.44
17 From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood 2011 1.41
18 The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol 2012 1.33
19 A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proc Natl Acad Sci U S A 2009 1.32
20 The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer. Breast Cancer Res 2010 1.29
21 Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res 2003 1.27
22 Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell 2011 1.25
23 Cul4A is an oncogene in malignant pleural mesothelioma. J Cell Mol Med 2011 1.21
24 Cancer evolution and individual susceptibility. Integr Biol (Camb) 2011 1.15
25 Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer. J Mol Med (Berl) 2012 1.12
26 Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr 2014 1.12
27 Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. J Clin Oncol 2010 1.10
28 CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to erlotinib via transcriptional regulation of EGFR. Mol Cancer 2014 1.06
29 Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors. Stem Cells 2014 1.05
30 Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development. Mol Cancer Res 2012 1.05
31 p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo. Oncogene 2005 1.04
32 Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathway. Cancer Res 2005 1.00
33 Genetic differences in transcript responses to low-dose ionizing radiation identify tissue functions associated with breast cancer susceptibility. PLoS One 2012 1.00
34 Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells. PLoS One 2012 0.99
35 C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes. Epigenetics 2013 0.98
36 Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev 2011 0.98
37 Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer. Mol Cancer Res 2011 0.96
38 Gene transcriptional networks integrate microenvironmental signals in human breast cancer. Integr Biol (Camb) 2010 0.96
39 FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7. Oncotarget 2013 0.96
40 Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas. Nat Commun 2013 0.95
41 Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells. Biochem Biophys Res Commun 2013 0.95
42 Temporal mTOR inhibition protects Fbxw7-deficient mice from radiation-induced tumor development. Aging (Albany NY) 2013 0.94
43 Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells. PLoS One 2012 0.89
44 Crosstalk between Pten and Ras signaling pathways in tumor development. Cell Cycle 2005 0.89
45 Allele-specific deletions in mouse tumors identify Fbxw7 as germline modifier of tumor susceptibility. PLoS One 2012 0.88
46 Sequence divergence of Mus spretus and Mus musculus across a skin cancer susceptibility locus. BMC Genomics 2008 0.88
47 Lung tumourigenesis in a conditional Cul4A transgenic mouse model. J Pathol 2014 0.86
48 Ptch1 overexpression drives skin carcinogenesis and developmental defects in K14Ptch(FVB) mice. J Invest Dermatol 2012 0.86
49 Evaluating the prognostic significance of FBXW7 expression level in human breast cancer by a meta-analysis of transcriptional profiles. J Cancer Sci Ther 2012 0.84
50 Transgenic mice for cre-inducible overexpression of the Cul4A gene. Genesis 2011 0.84
51 Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer. PLoS One 2010 0.82
52 Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms. Carcinogenesis 2012 0.82
53 Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis. Proc Natl Acad Sci U S A 2010 0.82
54 Persistent asymptomatic isolated hematuria in children: clinical and histopathological features and prognosis. World J Pediatr 2013 0.81
55 Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas. Blood 2011 0.81
56 Low-dose ionizing radiation-induced blood plasma metabolic response in a diverse genetic mouse population. Radiat Res 2012 0.81
57 Multiple novel alternative splicing forms of FBXW7α have a translational modulatory function and show specific alteration in human cancer. PLoS One 2012 0.79
58 Clinical Value of Assessing Cytokine Levels for the Differential Diagnosis of Bacterial Meningitis in a Pediatric Population. Medicine (Baltimore) 2016 0.79
59 Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach. Genome Biol 2015 0.78
60 Novel approaches to identify low-penetrance cancer susceptibility genes using mouse models. Recent Results Cancer Res 2003 0.78
61 Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes. Clin Cancer Res 2013 0.78
62 Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library. BMC Cancer 2009 0.78
63 Development of a rapid and practical mutation screening assay for human lung adenocarcinoma. Int J Oncol 2012 0.77
64 The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma. J Clin Pathol 2012 0.76
65 Frosted Branch Angiitis in Pediatric Dyskeratosis Congenita: A Case Report. Medicine (Baltimore) 2016 0.75
66 Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model. Int J Oncol 2013 0.75
67 [Twenty years follow-up: the correlation between sleep apnea syndrome and cerebrovascular disease]. Zhonghua Jie He He Hu Xi Za Zhi 2011 0.75
68 Unsupervised Transfer Learning via Multi-Scale Convolutional Sparse Coding for Biomedical Applications. IEEE Trans Pattern Anal Mach Intell 2017 0.75
69 Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells. Oncol Rep 2015 0.75
70 Corrigendum: Metabolomics reveals metabolic changes in male reproductive cells exposed to thirdhand smoke. Sci Rep 2016 0.75
71 Hypertonic glucose pleurodesis and surgical diaphragmatic repair for tension hydrothorax complicating continuous ambulatory peritoneal dialysis. Clin Nephrol 2016 0.75
72 Association between red blood cell distribution width and Henoch-Schonlein purpura nephritis. Medicine (Baltimore) 2017 0.75